HISUN(SH:600267)2015-10-26 16:00Financial Performance - Operating revenue decreased by 9.62% to CNY 6,707,052,217.24 for the first nine months compared to the same period last year[6] - Net profit attributable to shareholders decreased by 98.05% to CNY 4,431,478.87 for the first nine months compared to the same period last year[6] - Basic earnings per share decreased by 96.30% to CNY 0.01 per share compared to the same period last year[7] - The weighted average return on net assets decreased by 4.497 percentage points to 0.063% compared to the same period last year[7] - The company reported a net loss of CNY 35,974,231.59 attributable to shareholders for the first nine months[6] - The company’s net profit attributable to shareholders decreased by 98.05% to ¥4,431,478.87, mainly due to a reduction in profits[15] - Net profit for the first nine months of 2015 was CNY 161.73 million, down 72.55% from CNY 589.07 million in the same period last year[35] - The company reported a significant operating loss of CNY 85.94 million in Q3 2015, compared to a profit of CNY 120.80 million in Q3 2014[35] Assets and Liabilities - Total assets increased by 6.30% to CNY 18,388,591,658.56 compared to the end of the previous year[6] - Total liabilities and equity decreased by 1.53% to CNY 6,916,287,482.99 compared to the end of the previous year[6] - The company's financial assets measured at fair value decreased by 100% due to disposal[14] - Accounts receivable decreased by 40.98% to ¥124,082,363.29, primarily due to an increase in endorsed bills[14] - Prepayments increased by 114.06% to ¥279,018,692.54, mainly due to increased prepayments by subsidiaries[14] - Goodwill increased by 768.12% to ¥102,351,241.37, primarily due to investments in controlling subsidiaries[15] - The company's current assets totaled CNY 6.75 billion, down from CNY 6.91 billion at the beginning of the year[25] - The company's inventory increased to CNY 2.07 billion from CNY 1.67 billion at the beginning of the year, reflecting a growth of approximately 24%[25] - Total liabilities reached CNY 10.24 billion, up from CNY 9.03 billion at the beginning of the year, indicating a rise of about 13.4%[26] - The company's equity attributable to shareholders decreased to CNY 6.92 billion from CNY 7.02 billion, a decline of approximately 1.5%[26] Cash Flow - Cash flow from operating activities increased by 12.37% to CNY 597,842,880.22 for the first nine months compared to the same period last year[6] - Operating cash inflow for the first nine months of 2015 was CNY 7,232,630,451.70, a decrease of 10.7% compared to CNY 8,098,275,664.47 in the same period last year[41] - Net cash flow from operating activities increased to CNY 597,842,880.22, up 12.4% from CNY 532,022,811.31 year-on-year[41] - Cash flow from investment activities showed a net outflow of CNY 1,135,489,806.09, an improvement from a net outflow of CNY 1,683,003,152.96 in the previous year[42] - Cash flow from financing activities generated a net inflow of CNY 91,486,179.30, a significant decrease from CNY 2,450,495,273.46 in the same period last year[42] - Total cash and cash equivalents at the end of the period were CNY 2,020,249,402.13, down from CNY 3,445,020,433.89 at the end of the previous year[42] Investments and Subsidiaries - The company plans to establish a wholly-owned subsidiary in the United States with an investment of $5 million[17] - The company invested CNY 25 million in Zhejiang Jiayou Medical Equipment Co., holding a 33.33% stake, with CNY 7.5 million recorded as paid-in capital and CNY 17.5 million as capital reserve[18] - The company approved an additional investment of CNY 20 million in its wholly-owned subsidiary, Haizheng Pharmaceutical Nantong Co., increasing its registered capital to CNY 170 million[18] - Zhejiang Yunkai Yamei Pharmaceutical Technology Co., a subsidiary, plans to raise CNY 100 million by issuing 24.07407 million shares at CNY 4.15 each, with existing shareholders committing to subscribe for 3.611372 million shares[19] Shareholder Information - The total number of shareholders is 35,684[11] - Zhejiang Haizheng Group Co., Ltd. holds 320,783,590 shares, accounting for 33.22% of total shares[11] Revenue and Expenses - Sales revenue from goods and services received was CNY 6,890,698,182.24, a decline of 9.3% compared to CNY 7,593,723,238.72 in the same period last year[41] - The company received tax refunds amounting to CNY 30,850,263.36, down 62.7% from CNY 82,579,116.49 year-on-year[41] - The total operating costs for the first nine months of 2015 were ¥1,050.39 million, down from ¥1,222.77 million in the same period last year, a decrease of 14.1%[38] - The company's sales expenses for Q3 2015 were ¥106.17 million, a reduction of 58.1% from ¥252.92 million in Q3 2014[38] - The financial expenses for Q3 2015 were ¥24.21 million, down from ¥30.50 million in Q3 2014, showing a decrease of 20.5%[38] - The investment income for Q3 2015 was ¥12.29 million, an increase from ¥5.78 million in Q3 2014, representing a growth of 112.9%[38]